Keywords
surgical treatment
patients over 70 years
causes of death
survival
How to Cite
Abstract
One-year lethality was studied in 613 patients older than 70 years who underwent surgery for lung cancer for the period of 1970-2002. During the first year after surgery 166 patients died (27.1%) and besides from the generalization of the disease - 92.2%, from other causes - 7.8%. The highest rate of one-year lethality was observed after pneumonectomy (39.4%), the lowest one - after lung margins resection (16.5%). It was found that the most important factor in one-year lethality rate was N2 lymph node status. Risk of dying from the generalization of the disease during the first year sharply increased in group of patients underwent extended and combined pneumonectomy (one-year lethality of 52.6% and 57.1%, respectively), pneumonectomy with N2 (56,0%), lobectomy in peripheral cancer with metastases of N2 level (63,6%), especially when the amount of the tumor was more than 5 cm (83.3%).References
Вагнер Р.И. Вопросы диагностики и тактики хирургического лечения рака легкого. Автореферат дисс. докт. Л., 1973.
Давыдов М.И., Аксель Е.М. Статистика злокачественных новообразований в России и странах СНГ в 2009 году // Вестник РОНЦ им. Н.Н. Блохина РАМН. -2011. - Т. 22. - №. 3.- прил. 1.
Колбанов К.И., Трахтенберг А.Х., Франк Г.А. и др. Факторы прогноза, результаты хирургического и комбинированного лечения больных с различными морфологическими типами немелкоклеточного рака легкого // Онкология, журнал им. П.А.Герцена .- 2013. - № 3. - С. 11-16
Лактионов К.К., Давыдов М.И., Полоцкий Б.Е. и др. Прогностические и предсказывающие факторы у больных немелкоклеточным раком легкого // Практ. онкол. - 2006. - Т. 7. - № 3. - С. 145-153.
Мерабишвили В.М. Эпидемиология и оценка эффективности лечения больных раком легкого на популяционном уровне. Региональные аспекты инновационных технологий профилактики, диагностики, лечения и реабилитации больных профессиональными и производственно обусловленными заболеваниями верхних дыхательных путей и легких. //Сб. трудов Всерос. научно-практ. конф. Великий Новгород - Боровичи. -2013. - С. 142-145.
Пирогов А.И., Трахтенберг А.Х., Ерохов В.Ф. Значение лапароскопии и лапаротомии в определении распространенности рака легкого // Хирургия. - 1977. -№ 2. -С. 73-78.
Alexiou C., Beggs D., Rogers M.L. et al. Pneumonectomy for non-small cell lung cancer: predictors of operative mortality and survival // Eur J Cardiothorac Surg. - 2001. - Vol. 20 (3). - P. 476-480.
Boyle P., Ferlay J. Cancer incidence and mortality in Europe, 2004 // Ann Oncol. - 2005. -Vol. 16 (3). - P. 481-488.
D’Amico T.A., Massey M., Herndon J.E. 2nd et al. A biologic risk model for stage I lung cancer: immunohistochemical analysis of 408 patients with the use of ten molecular markers // J Thorac Cardiovasc Surg. - 1999. - Vol. 117 (4). - P 736-743.
Dominguez-Ventura A., Cassivi S.D., Allen M.S. et al. Lung cancer in octogenarians: factors affecting long-term survival following resection // Eur J Cardiothorac Surg. -2007. - Vol. 32 (2). - P. 370-374.
Ferlay J., Steliarova-Foucher E., Lortet-Tieulent J. et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012 // Eur J Cancer. - 2013. - Vol. 49 (6). - P. 1374-1403.
Fernandes O.J., Almgren S.O., Thaning L. et al. Prognostic factors for the survival of surgically treated patients for non-small cell lung cancer // Acta Oncol. - 2003. - Vol. 42 (4). - P 338-341.
Fontanini G., Vignati S., Bigini D. et al. Recurrence and death in non-small cell lung carcinomas: a prognostic model using pathological parameters, microvessel count, and gene protein products // Clin Cancer Res. - 1996. - Vol. 2 (6). - P. 1067-1075.
Harpole D.H. Jr., Herndon J.E. 2nd, Wolfe W.G. et al. A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression // Cancer Res. - 1995. - Vol. 55 (1). - P. 51-56.
Koizumi K. The revolution of thoracotomy for lung cancer surgery // Ann Thorac Cardiovasc Surg. - 2007. - Vol. 13 (4). - P. 228-235.
Lee P.C., Korst R.J., Port J.L. et al. Long-term survival and recurrence in patients with resected non-small cell lung cancer 1 cm or less in size // J Thorac Cardiovasc Surg. - 2006. - Vol. 132 (6). - P. 1382-1389.
Nonaka M., Kadokura M., Yamamoto S. et al. Tumor dimension and prognosis in surgically treated lung cancer: for intentional limited resection // Am J Clin Oncol. -2003. - Vol. 26 (5). - P 499-503.
Pelletier M.P., Edwardes M.D., Michel R.P. et al. Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis // Can J Surg. - 2001. - Vol. 44 (3). - P. 180-188.
Sagawa M., Sakurada A., Fujimura S. et al. Five-year survivors with resected pN2 nonsmall cell lung carcinoma // Cancer. - 1999. - Vol. 85 (4). - P. 864-868.
Strand T.E., Rostad H., Muller B., Norstein J. Survival after resection for primary lung cancer: a population based study of 3211 resected patients // Thorax. - 2006. -Vol. 61 (8). - P. 710-715.
Tammemagi C.M., Neslund-Dudas C., Simoff M., Kvale P. Impact of comorbidity on lung cancer survival // Int J Cancer. - 2003. - Vol. 103 (6). - P. 792-802.
Wao H., Mhaskar R., Kumar A. et al. Survival of patients with non-small cell lung cancer without treatment: a systematic review and meta-analysis // Syst Rev. - 2013. - 2:10.
Whittle J., Steinberg E.P., Anderson G.F., Herbert R. Use of Medicare claims data to evaluate outcomes in elderly patients undergoing lung resection for lung cancer // Chest. -1991. - Vol. 100 (3). - P 729-734.
Yano T., Fukuyama Y., Yokoyama H. et al. Long-term survivors with pN2 non-small cell lung cancer after a complete resection with a systematic mediastinal node dissection // Eur J Cardiothorac Surg. - 1998. - Vol. 14 (2). - P. 152-155.
All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical 'Problems in oncology' ...